www.3sbio.com 提示:

本信息仅供医学专业人士参考,如果您是医学专业人士,请点击确定后进入。 如果不是,请点击取消。

取消 确定

Products and services

In 3SBio, meeting the needs of patients is the core of all actions.

Our global list of drug combinations

The following is a list of products listed by our company, which is only for medical professionals to refer to.

BYETTA (Exenatide injection)

On October 11, 2016, we have entered into an exclusive license agreement with AstraZeneca to obtain the commercial rights of Byetta and Bydureon in China, which are valid for 20 years.

Indication Manufacturing base Dosage form&Dosage
The product is used to improve the glycemic control in patients with type 2 diabetes, which is suitable for those patients with poor glycemic control after single use of metformin, sulfonylurea or both AstraZeneca China Pen injector of 5 μg dose scale: 0.25 mg/ml, 1.2 ml/piece, single injection of 5 μg, containing injection dose for 60 times;
Pen injector of 10 μg: 0.25 mg/ml, 2.4ml/piece, single injection of 10 μg, containing injection dose for 60 times.

Humulin (recombinant insulin)

On May 16, 2017, the Company signed an exclusive license agreement with Lilly China, obtaining the commercialization rights for insulin product Humulin® in China.

Indication Manufacturing base Dosage form & Dosage
Diabetes Lilly China /